Is it safe to perform completion lobectomy after diagnostic wedge resection using video-assisted thoracoscopic surgery?

TY - JOUR

T1 - Is it safe to perform completion lobectomy after diagnostic wedge resection using video-assisted thoracoscopic surgery?

AU - Holbek, Bo Laksáfoss

AU - Petersen, René Horsleben

AU - Hansen, Henrik Jessen

PY - 2016/4/1

Y1 - 2016/4/1

N2 - OBJECTIVES: The objective of this study was to assess the safety of video-assisted thoracoscopic surgery (VATS) completion lobectomy (CL) for non-small cell lung cancer (NSCLC) after diagnostic wedge resection by comparing with standard VATS lobectomy (SL).METHODS: Data were retrieved from an institutional database of consecutive VATS lobectomies between January 1st 2007 and December 31st 2013. Patients were grouped into CL or SL. Patient characteristics, operative data, converted procedures, complications, and mortality was compared using Pearson Chi square, Fisher's exact test, or Mann-Whitney U test.RESULTS: In total 80 CL and 958 SLs were performed. There were no significant differences in median operating time, median chest drain duration or median length of stay. Median operative bleeding was 100 mL (IQR 50-238) in the CL group compared to 75 mL (IQR 25-200) in the SL group (p = 0.01). There were no differences between groups in major or minor complications. Median time from VATS wedge resection to CL was 33 days (IQR 27-41). Conversion rate was 1.3% in the CL group and 2.6% in the SL group (p = 0.72). 30-day mortality was 0 vs. 1.1 % for the CL group and the SL group accordingly (p > 0.99).CONCLUSIONS: This study comparing short-term surgical outcome and complications after surgical treatment of NSCLC indicates that VATS completion lobectomy after diagnostic wedge resection seems safe when looking at a relatively short time interval between the two procedures.

AB - OBJECTIVES: The objective of this study was to assess the safety of video-assisted thoracoscopic surgery (VATS) completion lobectomy (CL) for non-small cell lung cancer (NSCLC) after diagnostic wedge resection by comparing with standard VATS lobectomy (SL).METHODS: Data were retrieved from an institutional database of consecutive VATS lobectomies between January 1st 2007 and December 31st 2013. Patients were grouped into CL or SL. Patient characteristics, operative data, converted procedures, complications, and mortality was compared using Pearson Chi square, Fisher's exact test, or Mann-Whitney U test.RESULTS: In total 80 CL and 958 SLs were performed. There were no significant differences in median operating time, median chest drain duration or median length of stay. Median operative bleeding was 100 mL (IQR 50-238) in the CL group compared to 75 mL (IQR 25-200) in the SL group (p = 0.01). There were no differences between groups in major or minor complications. Median time from VATS wedge resection to CL was 33 days (IQR 27-41). Conversion rate was 1.3% in the CL group and 2.6% in the SL group (p = 0.72). 30-day mortality was 0 vs. 1.1 % for the CL group and the SL group accordingly (p > 0.99).CONCLUSIONS: This study comparing short-term surgical outcome and complications after surgical treatment of NSCLC indicates that VATS completion lobectomy after diagnostic wedge resection seems safe when looking at a relatively short time interval between the two procedures.

KW - Aged

KW - Carcinoma, Non-Small-Cell Lung/surgery

KW - Databases, Factual

KW - Female

KW - Humans

KW - Length of Stay

KW - Lung Neoplasms/surgery

KW - Male

KW - Middle Aged

KW - Operative Time

KW - Patient Safety

KW - Pneumonectomy/adverse effects

KW - Psychosurgery/methods

KW - Thoracic Surgery, Video-Assisted/adverse effects

U2 - 10.1007/s11748-016-0633-4

DO - 10.1007/s11748-016-0633-4

M3 - Journal article

C2 - 26914890

SN - 1863-6705

VL - 64

SP - 203

EP - 208

JO - General Thoracic and Cardiovascular Surgery

JF - General Thoracic and Cardiovascular Surgery

IS - 4

ER -